MYELOPROLIFERATIVE DISORDER side effect
What is MYELOPROLIFERATIVE DISORDER ?
Help Community - Describe Your Side Effect
Search FDA Side Effects
Ask Health Expert
MYELOPROLIFERATIVE DISORDER and Recently Reported Side Effects
MYELOPROLIFERATIVE DISORDER and 15 most Active Side Effect polls
MYELOPROLIFERATIVE DISORDER and featured health surveys
Substances toxic to Health
Recent Hospital reviews
Comments about Side Effects
Hospital Quality reviews
Homecare Quality reviews
Drugs associated with MYELOPROLIFERATIVE DISORDER
CLOZARIL MEPRONIZINE MICARDIS REMICADE REVLIMID ZYPREXARemicade Side Effects Report #5409457-0
Physician from UNITED STATES reported REMICADE problem on July 30, 2007. Male patient, weighting 124.0 lb, was diagnosed with crohn's disease and was treated with REMICADE. After drug was administered, patient experienced the following problems/side effects: myeloproliferative disorder, . REMICADE dosage: unknown. During the same period patient was treated with ASACOL. Patient recovered.
Micardis Side Effects Report #5726683-1
MICARDIS problem was reported by a Consumer or non-health professional from UNITED STATES on Apr 29, 2008. Male patient, weighting 201.0 lb, was diagnosed with cardiovascular disorder, cerebrovascular accident prophylaxis and was treated with MICARDIS. After drug was administered, patient experienced the following problems/side effects: myeloproliferative disorder, . MICARDIS dosage: unknown. During the same period patient was treated with LIPITOR, ASPIRIN. Patient recovered.
Clozaril Side Effects Report #5353434-5
Pharmacist from UNITED STATES reported CLOZARIL problem on June 04, 2007. Female patient, 64 years of age, was treated with CLOZARIL. After drug was administered, patient experienced the following problems/side effects: myeloproliferative disorder, white blood cell count decreased, . CLOZARIL dosage: 425 MG, QD. During the same period patient was treated with POTASSIUM ACETATE, EFFEXOR, HALDOL, DEPAKOTE, NEXIUM, ASPIRIN, ALBUTEROL. Patient recovered.
Zyprexa Side Effects Report #5509720-9
ZYPREXA problem was reported by a Physician from FRANCE on Nov 06, 2007. Male patient, weighting 253.5 lb, was diagnosed with schizophrenia, anxiety, hypercholesterolaemia and was treated with ZYPREXA. After drug was administered, patient experienced the following problems/side effects: leukopenia, myeloproliferative disorder, neutropenia, . ZYPREXA dosage: 10 MG, DAILY (1/D). During the same period patient was treated with OXAZEPAM, EFFEXOR, VALSARTAN, PRAVASTATIN, ASPIRIN. Patient was hospitalized. Patient recovered.
Revlimid Side Effects Report #5756493-0
Physician from UNITED STATES reported REVLIMID problem on May 20, 2008. Male patient, 61 years of age, was diagnosed with chronic myeloid leukaemia, myelodysplastic syndrome and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: infection, myeloproliferative disorder, pulmonary oedema, respiratory failure, sepsis, unevaluable event, . REVLIMID dosage: 25 MG, 1 IN 1 D, ORAL. Patient was hospitalized. Patient died on 02/04/2008.
Mepronizine Side Effects Report #5648499-7
MEPRONIZINE problem was reported by a Consumer or non-health professional from FRANCE on Feb 25, 2008. Male patient, 38 years of age, was treated with MEPRONIZINE. After drug was administered, patient experienced the following problems/side effects: condition aggravated, leukocytosis, myeloproliferative disorder, neutrophilia, . MEPRONIZINE dosage: unknown. During the same period patient was treated with TRANXENE, STILNOX, LEPONEX. Patient was hospitalized. Patient recovered.
Revlimid Side Effects Report #5772860-3
Physician from UNITED STATES reported REVLIMID problem on May 20, 2008. Male patient, 61 years of age, was diagnosed with chronic myeloid leukaemia, myelodysplastic syndrome and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: ill-defined disorder, infection, myeloproliferative disorder, pulmonary oedema, respiratory failure, sepsis, . REVLIMID dosage: 25 MG, 1 IN 1 D, ORAL. Patient was hospitalized. Patient died on 02/04/2008.